Literature DB >> 13796035

A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.

S J BAKER, E JACOB.   

Abstract

A bleeding disorder occurring during labour and affecting mother and foetus is described. All stages of coagulation were normal until the reaction fibrinogen-->fibrin. Either there was some abnormality present in the fibrinogen molecule, or there was an "anticoagulant" acting at this stage. The abnormality was reversible by protamine sulphate and toluidine blue, but in other respects did not resemble hyperheparinaemia. Reversibility of a clotting defect by protamine or toluidine blue is not sufficient evidence on which to make a diagnosis of hyperheparinaemia. Demonstration of a prolonged clotting time occurring in late pregnancy does not necessarily justify the diagnosis of "afibrinogenaemia."

Entities:  

Keywords:  FIBRIN; FIBRINOGEN; HEMORRHAGIC DIATHESIS/in pregnancy; PREGNANCY/blood

Mesh:

Substances:

Year:  1960        PMID: 13796035      PMCID: PMC480052          DOI: 10.1136/jcp.13.3.214

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Defibrination syndrome in pregnancy: value of various diagnostic tests.

Authors:  A A SHARP; B HOWIE; R BIGGS; D T METHUEN
Journal:  Lancet       Date:  1958-12-20       Impact factor: 79.321

2.  Incoagulability of blood after accidental haemorrhage.

Authors:  H C MOORE
Journal:  Br Med J       Date:  1954-07-31

3.  The action of thromboplastic substances.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-12-29       Impact factor: 5.182

4.  The identity and origin of the anticoagulant of anaphylactic shock in the dog.

Authors:  L B Jaques; E T Waters
Journal:  J Physiol       Date:  1941-06-30       Impact factor: 5.182

5.  A hemophilia-like disease with prolonged coagulation time and a circulating anticoagulant; report of a case in a female.

Authors:  O H DRESKIN; N ROSENTHAL
Journal:  Blood       Date:  1950-01       Impact factor: 22.113

6.  The nature of plasma antithrombin activity.

Authors:  P D KLEIN; W H SEEGERS
Journal:  Blood       Date:  1950-08       Impact factor: 22.113

  6 in total
  2 in total

1.  Defibrination syndrome with defective thrombinfibrinogen reaction reversible by protamine.

Authors:  A L Bloom; N Campbell
Journal:  J Clin Pathol       Date:  1965-11       Impact factor: 3.411

2.  A puerperal haemorrhagic state due to a henarin-like anticoagulant.

Authors:  M L WILLOUGHBY
Journal:  J Clin Pathol       Date:  1963-03       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.